In 34 hepatocellular carcinoma patients (44 lesions), proton irradiation was performed and assessed. Proton irradiation was effective for the nodular HCCin terms of tumor size reduction and histology and almost 100%local tumor control was obtained during the observation period of at least 2 years, which is still undergoing up to 4 years. This therapy is safe and has the merit of excellent QOL during the treatment without any complaints. Further, this method is feasible for patients ofdeepseated tumors, and for those with serious complications. Due to the excellent local tumor control, the determining factor for the survival is not affected by the proton irradiation but by the associated complications such as liver cirrhosis.
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Background
Conventional external radiotherapy has limited success in hepatocellular carcinoma (HCC), and is not always a recommendable approach amongthe treatment options. The reason is the severe adverse effects, such as hepatic failure, caused by irradiation accompanying cirrhotic liver. Thus, doses large enough to achieve anticancer effects cannot be accomplished.
The proton beam has a Bragg peak that can limit distribution of the beam, whichreduces radiation to the non-targeted area while increasing that hitting the target. Recently, we preliminary reported that a large quantity of protons can be safely Proton Irradiation for Hepatocellular Carcinoma administered to HCCpatients with pre-existing cirrhosis ( 1) . In the present study, wedemonstrate the details of the first trial of proton irradiation for hepatocellular carcinoma.
Patients and Methods

Patients
Our study was approved by the Ethical Committee for Proton Radiotherapy at Tsukuba University Hospital. Thirtyfour patients with HCCgave their informed consent and received proton beamradiotherapy at the Proton Medical Research Center (PMRC) , University ofTsukuba, in collaboration with the National Laboratory for High Energy Physics (KEK) between January 1988 and October 1992. Table 1 lists the characteristics of these 34 patients and their 44 tumors.
Proton irradiation procedures
The protons were provided by a booster synchrotron ofKEK and their energy was reduced from 500 to 250 MeVbefore use. The quantity of radiation was 3-4 Gy per treatment and the (3) (4) (5) (6) . It has been assumed that more than 50 Gy should be targeted for killing HCCcells (7) . But the conventional approaches in which the whole liver is irradiated have caused radiation hepatitis and eventual hepatic failure, especially in patients complicated with cirrhosis. Therefore, sufficient irradiation of a large quantity and long duration to obtain effective antineoplastic effects for mostcases of HCChas not been possible (6) (7) . Unlike the conventional radiation beam, the proton beam has a unique beamdistribution: the beam distribution rate is less in deeper sites than in thinner, superficial sites and there is a peak area (Bragg peak) which rapidly stands around the end of the range at a specific depth-responding energy. The technique has an advantage in that a large amount of radiation can be focused only on the lesion and the exposure of surrounding nontumor tissue can be limited to as little as possible. In fact, with this proton beam it is possible to safely deliver a large quantity of radiation (an amount as large as 3 to 4 Gy per treatment for a total of 76.5 Gy [mean]).
In the present study, we selected the patients with HCCwho could not be treated by other conventional methods because of unresectable tumor, serious complications or the patient's refusal. Despite these handicap conditions proton therapy was effective enoughto reduce the tumorsize and to makeviable cancer cells disappear. It is noteworthy that the incidence of side effects of proton therapy were very low, and none of the patients have experienced any serious adverse effects necessitating discontinuation of the irradiation protocol. All of the patients maintained typical usual life style during proton therapy. Therefore, satisfactory QOLwas insured. According to an international survey, approximately 1 0,000 patients were been treated with proton beams between 1 954 and June 1991 at 1 1 facilities in 5 countries (8) . Worldwide experience with proton radiotherapy have indicated substantial clinical advantages in relatively superficial and slowly growing tumors (9, 10), but not in deep-seated tumors. However, the present results have demonstrated that the proton beamwas effective even for tumors which are deep seated.
In conclusion, proton irradiation therapy is safe and has the special merit of excellent QOLduring the treatment without any complaints. This method is advantageous because it is applicable for deep-seated tumors and for patients with serious complications.
